Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
AMAG Pharmaceuticals Inc. (AMAG)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: AMAG
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on AMAG
Mike Havrilla
(1925 followers)
Rockwell Medical's Potential for Exponential Gains
(Wed, Sep 2)
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
(Wed, Jul 1)
FDA Calendar Updates: AMAG Pharma, Takeda
(Tue, Jun 30)
More by Mike Havrilla on AMAG »
Zacks.com
(1051 followers)
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
(Tue, Jun 2)
3S Bio: Post-Earnings, Still a Buy
(Thu, May 21)
Know Your Options When Investing in Biotech Stocks
(Mon, Mar 2)
More by Zacks.com on AMAG »
Market Folly
(1970 followers)
Galleon Bets Heavily on the S&P 500
(Tue, Jun 9)
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
(Tue, Apr 21)
Hedge Fund Portfolio Tracking: Galleon Group (Raj Rajaratnam), Q3 2008
(Fri, Jan 16)
More by Market Folly on AMAG »
Most followed authors on AMAG
TraderMark
(3719 followers)
Sequenom's Bombshell
(Thu, Apr 30)
More by TraderMark on AMAG »
Market Folly
(1970 followers)
Galleon Bets Heavily on the S&P 500
(Tue, Jun 9)
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions
(Tue, Apr 21)
Hedge Fund Portfolio Tracking: Galleon Group (Raj Rajaratnam), Q3 2008
(Fri, Jan 16)
More by Market Folly on AMAG »
Mike Havrilla
(1925 followers)
Rockwell Medical's Potential for Exponential Gains
(Wed, Sep 2)
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
(Wed, Jul 1)
FDA Calendar Updates: AMAG Pharma, Takeda
(Tue, Jun 30)
More by Mike Havrilla on AMAG »
Newest authors on AMAG
Nikos Celletia
(2 followers)
AMAG Pharmaceuticals' Feraheme: The Next Billion Dollar Drug
(Mon, Aug 3)
More by Nikos Celletia on AMAG »
Kaushik Paul
(78 followers)
Expect FDA Approval of AMAG Pharmaceutical's Feraheme
(Fri, Jun 26)
More by Kaushik Paul on AMAG »
Michael Johnston
(409 followers)
Biotech ETFs Surge Again on M&A News
(Fri, Jul 24)
More by Michael Johnston on AMAG »
Most commented on AMAG
Zacks.com
(1051 followers)
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
(Tue, Jun 2)
3S Bio: Post-Earnings, Still a Buy
(Thu, May 21)
Know Your Options When Investing in Biotech Stocks
(Mon, Mar 2)
More by Zacks.com on AMAG »
Mike Havrilla
(1925 followers)
Rockwell Medical's Potential for Exponential Gains
(Wed, Sep 2)
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG
(Wed, Jul 1)
FDA Calendar Updates: AMAG Pharma, Takeda
(Tue, Jun 30)
More by Mike Havrilla on AMAG »
Kaushik Paul
(78 followers)
Expect FDA Approval of AMAG Pharmaceutical's Feraheme
(Fri, Jun 26)
More by Kaushik Paul on AMAG »